|
| |
BioPortfolio's Approved Drugs DatabaseOluxClobetasol PropionateDownload PDF containing detailed information.
Press Releases About Olux:
|
 |
| GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business |
20th April, 2009 |
GlaxoSmithKline plc |
Stiefel, the world's largest independent dermatology company, acquired by GSK in deal valued at up to $3.6 billion
New global business will have combined revenues of approximately $1.5 billion
|
| Excaliard Pharmaceuticals Appoints Lincoln Krochmal, MD, President & Chief Executive Officer and Jeffrey Jenson, Head of Clinical Operations. |
10th October, 2008 |
Excaliard Pharmaceuticals |
CARLSBAD, Calif., Oct. 10 /PRNewswire/ -- Excaliard Pharmaceuticals, a late stage preclinical company developing targeted therapeutics for the treatment of dermatological disorders and fibrotic
|
| Stiefel Laboratories Completes Acquisition of Barrier Therapeutics |
6th August, 2008 |
Stiefel Laboratories, Inc. |
CORAL GABLES, Fla., Aug. 6 /PRNewswire/ -- Stiefel Laboratories, Inc., the
world's largest independent pharmaceutical company specializing in
dermatology, announced today that it has
|
| Stiefel Laboratories, Inc. Successfully Completes Tender Offer for Shares of Barrier Therapeutics, Inc. |
5th August, 2008 |
Stiefel Laboratories, Inc. |
CORAL GABLES, Fla., Aug. 5 /PRNewswire/ -- Stiefel Laboratories, Inc.
("Stiefel Laboratories"), the world's largest independent pharmaceutical
company specializing in dermatology,
|
| Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc. |
29th July, 2008 |
Stiefel Laboratories, Inc. |
CORAL GABLES, Fla., July 29 /PRNewswire/ -- Stiefel Laboratories, Inc.
("Stiefel Laboratories"), the world's largest independent pharmaceutical
company specializing in dermatology,
|
Companies working in the area of Olux from Bioportfolio's Biocorporate database : |  |
| Company Name | |
Connetics Corporation is focused on the acquisition, development and commercialization of marketed and late-stageproducts. The Company's product and commercial focus is initially targeted at...
www.connetics.com/ View full profile
| |
Connetics Corporation is a specialty pharmaceutical company focused on the development and commercialization of innovative therapeutics for the dermatology market. The Company's marketed products are...
www.connetics.com/ View full profile
| |
Pranalytica, Inc. started operations in February 2000 and has developed revolutionary ultra-sensitive trace gas detection instrumentation that enables monitoring of: • Airborne ammonia contamination...
www.pranalytica.com/ View full profile
| | →View more Olux related companies. |
This page has been viewed 27 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Olux across BioPortfolio, or for Olux Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|